ITB-MED Information
Summary
ITB-MED is a private company that has been in the industry for 10 years. The company currently specializes in the Biotechnology area. The position of the Founder & CEO is occupied by Erik Berglund. Its headquarters is located at Stockholm, Stockholms län, SE. The ITB-MED annual revenue is estimated at < 1M. Total funding of the company - $67M. To connect with ITB-MED employee register on SignalHire.
Organization Website | itb-med.com |
Industries | |
Headquarters Location | 110 E 59th St, New York, 10022 US |
Employees Size | 10-50 employees |
Specialties | Transplantation Surgery, Immunology, Monoclonal antibodies |
Founded | 2016 |
Operating Status | Independent Company |
Employees Turnover 4 quarter 2025
Number of employees switched from or switched to
Length of Employment
Employee tenure at ITB-MED shows a diverse range of experience levels:
6% have been with the company for less than 1 year22% for 1–2 years50% for 3–4 years17% for 5–7 years6% for 8–10 yearsEx-employees positions
Similar Companies
FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
